SynthesisFrontiers in medicine2026
Pulmonary rehabilitation in post-tuberculosis lung disease: a systematic review.
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Tuberculosis (TB) remains a significant global health concern, resulting in illness and death for millions of individuals. Despite the availability of effective treatment options, a substantial number of people continue to suffer from long-term lung consequences known as post-tuberculosis lung disease (PTLD). PTLD may be associated with reduced exercise capacity, respiratory impairment, and diminished quality of life. Pulmonary rehabilitation (PR), an intervention that combines exercise and education to enhance pulmonary function and overall wellbeing, may offer a solution. The aim of this systematic review was to map the available evidence on PR interventions for PTLD, identify gaps in the literature, and synthesize findings on exercise capacity, quality of life, pulmonary function, and symptom outcomes to inform clinical practice and future research. Methods: A systematic search was conducted across four electronic databases, Scopus, PubMed (MEDLINE), ProQuest, and EBSCO, for studies published between 2000 and 2026. The overall search yielded 1,085 articles. After reviewing titles and abstracts, we removed 163 duplicates and excluded 905 articles. A total of 17 articles met the inclusion criteria and were included in this systematic review. Results: Seventeen studies met the inclusion criteria, encompassing randomized controlled trials (RCTs) and observational study designs across multiple countries. PR consistently improved exercise capacity, with a 6 min walk distance (6MWD) increasing by 36-189 m (440.6 ± 70.8 m to 574.6 ± 168.9 m; 399 ± 62 m to 467 ± 65 m, Conclusion: Despite certain limitations, all included studies demonstrated improvement in at least one key outcome domain. They collectively suggest that PR may be a valuable component of PTLD management, though further high-quality trials are needed to establish optimal protocols and confirm efficacy. PR has the potential to enhance the quality of life, exercise capacity, and lung function in patients with post-TB complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.